Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer:: One institution's experience

被引：29
|
作者：
Wu, Bin [2 ]
Zhu, Jin-Shui [1 ]
Zhang, Yi [2 ]
Shen, Wei-Ming [2 ]
Zhang, Qiang [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Hosp Affiliated 6, Shanghai 200223, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Pharm, Shanghai Hosp Affiliated 6, Shanghai 200223, Peoples R China
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2008年 / 14卷 / 19期
关键词：
gastric cancer; chemosensitivity testing; chemotherapy; MTT assay; survival rate;
D O I：
10.3748/wjg.14.3064
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
AIM: To investigate the predictive clinical value of in vitro 3-(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) assay for directing chemosensitivity in patients with gastric cancer. METHODS: Results of a total of 353 consecutive patients with gastric cancer treated with MTT-directed chemotherapy or physician's empirical chemotherapy from July 1997 to April 2003 were reviewed and analyzed retrospectively. RESULTS: The overall 5-year survival rate of MTT-sensitive group (MSG) and control group (CG) was 47.5% and 45.1%, respectively. The results of subgroup analysis with Cox proportional-hazards model were favorable for the MSG-sensitive group. However, no statistically significant difference in survival rate was observed between the two groups. CONCLUSION: Individualized chemotherapy based on in vitro MTT assay is beneficial, but needs to be confirmed by further randomized controlled trials. (C) 2008 WJG. All rights reserved.
引用
收藏
页码：3064 / 3068
页数：5
相关论文
共 50 条
  • [41] Predictive Value of Pre-Operative Thyroid FNA BRAF Mutation Testing for Risk of Lymph Node Thyroid Carcinoma Metastases: A Single Institution Experience of 498 Cases
    Ustun, B.
    Adeniran, A.
    Cai, G.
    Roman, S.
    Sosa, J. A.
    Holt, E.
    Chhieng, D. C.
    Theoharis, C. G. A.
    MODERN PATHOLOGY, 2013, 26 : 105A - 105A
  • [42] Predictive Value of Pre-Operative Thyroid FNA BRAF Mutation Testing for Risk of Lymph Node Thyroid Carcinoma Metastases: A Single Institution Experience of 498 Cases
    Ustun, B.
    Adeniran, A.
    Cai, G.
    Roman, S.
    Sosa, J. A.
    Holt, E.
    Chhieng, D. C.
    Theoharis, C. G. A.
    LABORATORY INVESTIGATION, 2013, 93 : 105A - 105A
  • [43] Uninterrupted moderately accelerated radiotherapy in the treatment of unresectable/advanced head and neck cancer - One institution's experience and a comparative review
    Dowlatshahi, M
    Iganej, S
    Ciabatone, A
    Peddada, A
    Miller, M
    Tome, M
    Rao, A
    Ryoo, M
    Becker, G
    McNicoll, M
    Morgan, T
    Ryoo, J
    Kagan, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (02): : 149 - 154
  • [44] One practitioner's experience with counseling and testing women at risk for hereditary breast and ovarian cancer syndrome.
    Tatum, Tracey
    ONCOLOGY NURSING FORUM, 2007, 34 (02) : 496 - 497
  • [45] Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients
    Katarzyna Gęca
    Magdalena Skórzewska
    Karol Rawicz-Pruszyński
    Radosław Mlak
    Katarzyna Sędłak
    Zuzanna Pelc
    Teresa Małecka-Massalska
    Wojciech P. Polkowski
    Scientific Reports, 12
  • [46] Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients
    Geca, Katarzyna
    Skorzewska, Magdalena
    Rawicz-Pruszynski, Karol
    Mlak, Radoslaw
    Sedlak, Katarzyna
    Pelc, Zuzanna
    Polkowski, Wojciech P.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [47] UTILIZING PERIPHERAL BLOOD HEMATOPOIETIC PROGENITOR CELL COUNT TO IMPROVE PERIPHERAL STEM CELL COLLECTION: ONE CANCER INSTITUTION'S EXPERIENCE
    Moung, C.
    Tonon, J.
    Smith, K. M.
    Reich, L.
    Maslak, P.
    Meagher, R. C.
    Wuest, D.
    Peerschke, E. I.
    Pessin, M. S.
    CYTOTHERAPY, 2013, 15 (04) : S26 - S26
  • [48] PREDICTIVE VALUE OF PARTIN'S NOMOGRAM IN DIAGNOSING PROSTATIC CANCER AT BIOPSY: THE VILLA TIBERIA CLINICAL EXPERIENCE FROM 2007 TO 2010
    Giulianelli, Roberto
    Albanesi, Luca
    Attisani, Francesco
    Brunori, Stefano
    Gentile, Barbara
    Mavilla, Luca
    Mirabile, Gabriella
    Pisanti, Francesco
    Shestani, Teuta
    Vincenti, Giorgio
    Schettini, Manlio
    ANTICANCER RESEARCH, 2011, 31 (05) : 1837 - 1837
  • [49] Author Correction: Prognostic value of molecular cytology by one‑step nucleic acid amplifcation (OSNA) assay of peritoneal washings in advanced gastric cancer patients
    Katarzyna Gęca
    Magdalena Skórzewska
    Karol Rawicz‑Pruszyński
    Radosław Mlak
    Katarzyna Sędłak
    Zuzanna Pelc
    Teresa Małecka‑Massalska
    Wojciech P. Polkowski
    Scientific Reports, 13 (1)
  • [50] Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience
    Menon, Anitha
    Perry, D. Alex
    Motyka, Jonathan
    Weiner, Shayna
    Standke, Alexandra
    Penkevich, Aline
    Keidan, Micah
    Young, Vincent B.
    Rao, Krishna
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2883 - E2889
12345